Asia Pacific Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)
The Asia Pacific parenteral nutrition market was valued at US$ 861.59 million in 2022 and is expected to reach US$ 1,471.33 million by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.
New Product Developments by Companies Boost Asia Pacific Parenteral Nutrition Market
Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:
In 2023, Baxter Korea launched Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) fluid for critically ill patients.
In 2023, JW Holdings started exporting Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), on a large scale to Mongolia via AsiaPharma LLC, a local pharmaceutical company.
Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.
Asia Pacific Parenteral Nutrition Market Overview
China faces a high burden of stomach cancer due to the growing prevalence of H. pylori infection among the people. A study (2021) by the World Health Organization's International Agency for Research on Cancer (IARC) and partner institutions in the UK and China found that H. pylori infection is prevalent in China. Furthermore, H. pylori infection was the prime cause for 62.1% of cardia gastric cancer cases and 78.5% of non-cardia gastric cancer cases among adults over 30 years of age. This study by IARC estimated that ~340,000 cases of gastric cancer due to H. pylori infection occur in China every year. According to Global Burden of Diseases study published in October 2020, stomach cancer was among the top 10 causes of death in 2019. Similarly, according to the latest data from the International Agency for Research on Cancer (IARC), the estimated age-standardized incidence rate for stomach cancer in China is 20.58 per 100,000, and the crude rate is 33.06. As per the same source, the estimated number of new cases (aged 0-74) in 2020 for both sexes was 478,508. Thus, owing to the abovementioned factors, the market for parenteral nutrition is likely to witness remarkable growth in China during the forecast period.
Asia Pacific Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Segmentation
The Asia Pacific parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Asia Pacific is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.
By end user, the Asia Pacific is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific share in 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Asia Pacific .
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market - Asia Pacific Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Parenteral Nutrition Market Analysis - by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Parenteral Nutrition Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Vifor Pharma Management AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Aculife Healthcare Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Parenteral Nutrition Market Segmentation
Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market
List of Figures
Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.